RUNX3 and cancer: Since suppression of RUNX3 expression in 544 cells attenuated the xenograft tumor growth in recipient mice, we addressed whether RUNX3 in the exp‐CAFs contributes to co‐injected cancer cell proliferation and to neoangiogenesis in the tumors.